Search results for “RESPIRATORY DISTRESS SYNDROME ADULT” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 734 patents, we discovered top 135 key players by total patent application. Ranbaxy Laboratories Ltd., Amgen, Inc., Pfizer Inc. are dominant in this area. They take 18.39% of the total patent filing.
Ranbaxy Laboratories Ltd.
Haryana, India
Patent: 67
Amgen, Inc.
California, United States
Patent: 35
Pfizer Inc.
New York, United States
Patent: 33
Cortech, Inc.
New Jersey, United States
Patent: 33
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 32
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 27
Fujisawa Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 26
Pieris Pharmaceuticals GmbH
Germany
Patent: 18
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 17
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 17
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 19 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Pieris Pharmaceuticals GmbH, AstraZeneca Pharmaceutical Co., Ltd., California Institute of Technology take 89.47% of patent filing during this period.
Pieris Pharmaceuticals GmbH
Germany
Patent: 7
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 7
California Institute of Technology
California, United States
Patent: 3
The Scripps Research Institute
California, United States
Patent: 1
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 1
Vascular BioSciences, Inc.
California, United States
Patent: 1
Seoul National University Hospital
South Korea
Patent: 1
Edwards Lifesciences Corp.
California, United States
Patent: 1
Aerpio Therapeutics, Inc.
Ohio, United States
Patent: 1
Shanghai Kaiyi Pharmaceutical Technology Co., Ltd.
China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 19 patents in last 5 years, we discover 4 new entrants. California Institute of Technology, Merck Sharp & Dohme LLC, Seoul National University Hospital are the most active new entrants in this area.
California Institute of Technology
California, United States
Patent: 3
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 1
Seoul National University Hospital
South Korea
Patent: 1
Shanghai Kaiyi Pharmaceutical Technology Co., Ltd.
China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 134 patents, we discovered top 17 universities and scientific research institutions by total patent application. The Scripps Research Institute, The Johns Hopkins University, Yale University are dominant in this area. They take 43.28% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 17
The Johns Hopkins University
United States
Patent: 10
Yale University
Connecticut, United States
Patent: 9
Regents of the University of Colorado
Colorado, United States
Patent: 9
The Rockefeller University
New York, United States
Patent: 6
University of Stellenbosch
South Africa
Patent: 6
McMaster University
Ontario, Canada
Patent: 5
California Institute of Technology
California, United States
Patent: 3
University of Utah
Utah, United States
Patent: 2
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: